Act for Skin

Today, 30 to 60%* of cancer patients experience skin-related side effects from their cancer treatment.
That is why the Pierre Fabre Group launched the international ACT FOR SKIN program, dedicated to the prevention and management of skin side effects related to cancer and its treatments. It is aimed at both patients and healthcare professionals (oncologists, dermatologists, nurses, primary care physicians, and pharmacists) and draws on the dermo-cosmetic and medical expertise of brands such as Eau Thermale Avène, Ducray, A-derma, and Oral Care.
The goal of Act for Skin isto improve patients’ quality of life by incorporating dermocosmetic supportive care throughout their cancer treatments.
Multidisciplinary Expert Panel
The "Act for Skin, Care for Cancer Patients" project is supported by an advisory board composed of key opinion leaders, including 3 oncodermatologists, 2 oncologists, 1 pharmacist, and apatient organization
The objectives are as follows:
- Develop multidisciplinary recommendations
- Strengthen education for patients and caregivers
- Integrate artificial intelligence (AI) into patient care

Treatments specifically tested on patients undergoing cancer treatment
Every product in the program is specifically tested on patients with cancer. Our teams
combine medical, dermo-cosmetic, and real-world research expertise to ensure efficacy and
tolerability.
The program also includes post-cancer creenotherapy at the Avène Thermal Center, whose
benefits for quality of life have been demonstrated
Find the tools to help you with prescribing and support your patients:






